Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma

Oncolytic virus therapy leads to immunogenic death of virus-infected tumor cells and this has been shown in preclinical models to enhance the cytotoxic T-lymphocyte response against tumor-associated antigens (TAAs), leading to killing of uninfected tumor cells. To investigate whether oncolytic virot...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leukemia
Autors principals: Packiriswamy, Nandakumar, Upreti, Deepak, Zhou, Yumei, Khan, Rehan, Miller, Amber, Diaz, Rosa M., Rooney, Cliona M., Dispenzieri, Angela, Peng, Kah-Whye, Russell, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581629/
https://ncbi.nlm.nih.gov/pubmed/32327728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-020-0828-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars